Serology reflects a decline in the prevalence of trachoma in two regions of The Gambia

[1]  C. Roberts,et al.  Prevalence of signs of trachoma, ocular Chlamydia trachomatis infection and antibodies to Pgp3 in residents of Kiritimati Island, Kiribati , 2017, PLoS neglected tropical diseases.

[2]  M. Burton,et al.  Age-specific prevalence of anti-Pgp3 antibodies and severe conjunctival scarring in the Solomon Islands , 2017, bioRxiv.

[3]  D. Mabey,et al.  Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies , 2017, PLoS neglected tropical diseases.

[4]  D. Mabey,et al.  Eyelash Epilation in the Absence of Trichiasis: Results of a Population-Based Prevalence Survey in the Western Division of Fiji , 2017, PLoS neglected tropical diseases.

[5]  D. Mabey,et al.  Community seroprevalence survey for yaws and trachoma in the Western Division of Fiji , 2016, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[6]  A. Wadagni,et al.  Cross-Sectional Surveys of the Prevalence of Follicular Trachoma and Trichiasis in The Gambia: Has Elimination Been Reached? , 2016, PLoS neglected tropical diseases.

[7]  B. Munoz,et al.  The World Health Organization Recommendations for Trachoma Surveillance, Experience in Nepal and Added Benefit of Testing for Antibodies to Chlamydia trachomatis pgp3 Protein: NESTS Study , 2016, PLoS neglected tropical diseases.

[8]  H. Tutill,et al.  Low Prevalence of Conjunctival Infection with Chlamydia trachomatis in a Treatment-Naïve Trachoma-Endemic Region of the Solomon Islands , 2016, PLoS neglected tropical diseases.

[9]  C. Bottomley,et al.  Mass drug administration of azithromycin for trachoma reduces the prevalence of genital Chlamydia trachomatis infection in the Solomon Islands , 2016, Sexually Transmitted Infections.

[10]  M. White,et al.  Antibody acquisition models: A new tool for serological surveillance of malaria transmission intensity , 2016, Scientific Reports.

[11]  B. Munoz,et al.  Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey , 2016, PLoS neglected tropical diseases.

[12]  C. Drakeley,et al.  Sample size and power calculations for detecting changes in malaria transmission using antibody seroconversion rate , 2015, Malaria Journal.

[13]  M. Gambhir,et al.  Serological Measures of Trachoma Transmission Intensity , 2015, Scientific Reports.

[14]  Marleen Temmerman,et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.

[15]  G. Stresman,et al.  Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication , 2015, Journal of immunology research.

[16]  the IndiSeas Working Group.  Targeting vivax malaria in the Asia Pacific: The Asia Pacific Malaria Elimination Network Vivax Working Group , 2015, Malaria Journal.

[17]  D. Conway,et al.  Serology describes a profile of declining malaria transmission in Farafenni, The Gambia , 2015, Malaria Journal.

[18]  C. Mercer,et al.  Can we use postal surveys with anonymous testing to monitor chlamydia prevalence in young women in England? Pilot study incorporating randomised controlled trial of recruitment methods , 2015, Sexually Transmitted Infections.

[19]  S. Brooker,et al.  The Global Trachoma Mapping Project: Methodology of a 34-Country Population-Based Study , 2015, Ophthalmic epidemiology.

[20]  M. Jofre-Bonet,et al.  Costs of Testing for Ocular Chlamydia trachomatis Infection Compared to Mass Drug Administration for Trachoma in The Gambia: Application of Results from the PRET Study , 2015, PLoS neglected tropical diseases.

[21]  C. Drakeley,et al.  Serology for Trachoma Surveillance after Cessation of Mass Drug Administration , 2015, PLoS neglected tropical diseases.

[22]  M. Jimba,et al.  Caregivers’ treatment-seeking behaviour for children under age five in malaria-endemic areas of rural Myanmar: a cross-sectional study , 2015, Malaria Journal.

[23]  B. Munoz,et al.  Longitudinal analysis of antibody responses to trachoma antigens before and after mass drug administration , 2014, BMC Infectious Diseases.

[24]  Gretchen A. Stevens,et al.  Causes of vision loss worldwide, 1990-2010: a systematic analysis. , 2013, The Lancet. Global health.

[25]  Joshua T. Davis,et al.  Timing and circumstances of first sex among female and male youth from select urban areas of Nigeria, Kenya, and Senegal. , 2013, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[26]  L. F. Chaves,et al.  Characteristic Age Distribution of Plasmodium vivax Infections after Malaria Elimination on Aneityum Island, Vanuatu , 2013, Infection and Immunity.

[27]  S. West,et al.  Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia , 2013, PLoS neglected tropical diseases.

[28]  Anne M Johnson,et al.  Effect of time since exposure to Chlamydia trachomatis on chlamydia antibody detection in women: a cross-sectional study , 2013, Sexually Transmitted Infections.

[29]  B. Munoz,et al.  CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs , 2012, PLoS neglected tropical diseases.

[30]  Jennifer R. Evans,et al.  Antibiotics for trachoma. , 2011, The Cochrane database of systematic reviews.

[31]  E. Cromwell,et al.  Incremental Cost of Conducting Population-Based Prevalence Surveys for a Neglected Tropical Disease: The Example of Trachoma in 8 National Programs , 2011, PLoS neglected tropical diseases.

[32]  B. Munoz,et al.  Trachoma Prevalence and Associated Risk Factors in The Gambia and Tanzania: Baseline Results of a Cluster Randomised Controlled Trial , 2010, PLoS neglected tropical diseases.

[33]  M. Burton,et al.  Profound and Sustained Reduction in Chlamydia trachomatis in The Gambia: A Five-Year Longitudinal Study of Trachoma Endemic Communities , 2010, PLoS neglected tropical diseases.

[34]  G. Zhong,et al.  A Genome-Wide Profiling of the Humoral Immune Response to Chlamydia trachomatis Infection Reveals Vaccine Candidate Antigens Expressed in Humans , 2010, The Journal of Immunology.

[35]  D. Mabey,et al.  Active Trachoma and Ocular Chlamydia trachomatis Infection in Two Gambian Regions: On Course for Elimination by 2020? , 2009, PLoS neglected tropical diseases.

[36]  E. Paintsil,et al.  Association of Age at First Sex With HIV-1, HSV-2, and Other Sexual Transmitted Infections Among Women in Northern Tanzania , 2009, Sexually transmitted diseases.

[37]  A. Ndiaye,et al.  [Screening for HIV, syphilis, Chlamydia trachomatis and Neisseria gonorrhoreae during a combined survey conducted in Malicouna, a Senegalese rural area]. , 2009, Bulletin de la Societe de pathologie exotique.

[38]  N. Grassly,et al.  The Development of an Age-Structured Model for Trachoma Transmission Dynamics, Pathogenesis and Control , 2009, PLoS neglected tropical diseases.

[39]  Anne M Johnson,et al.  Pgp3 Antibody Enzyme-Linked Immunosorbent Assay, a Sensitive and Specific Assay for Seroepidemiological Analysis of Chlamydia trachomatis Infection , 2009, Clinical and Vaccine Immunology.

[40]  G. Ritschard,et al.  The start of the sexual transition in Mali: risks and opportunities. , 2008, Studies in family planning.

[41]  Teun Bousema,et al.  Dried blood spots as a source of anti-malarial antibodies for epidemiological studies , 2008, Malaria Journal.

[42]  D. Mabey,et al.  Two doses of azithromycin to eliminate trachoma in a Tanzanian community. , 2008, The New England journal of medicine.

[43]  J. Cox,et al.  Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  R. Peeling,et al.  Mass treatment with single-dose azithromycin for trachoma. , 2004, The New England journal of medicine.

[45]  C. Bruggeman,et al.  Chlamydia antibody testing in screening for tubal factor subfertility: the significance of IgG antibody decline over time. , 2002, Human reproduction.

[46]  L. Morison,et al.  The burden of reproductive-organ disease in rural women in The Gambia, West Africa , 2001, The Lancet.

[47]  G. Johnson,et al.  Evaluation of a national eye care programme: re-survey after 10 years , 2000, The British journal of ophthalmology.

[48]  P. S. Lee,et al.  Trachoma in the Gambia , 1998, The British journal of ophthalmology.

[49]  A. Foster,et al.  Reduction of trachoma in a sub-Saharan village in absence of a disease control programme , 1997, The Lancet.

[50]  H. Whittle,et al.  Polymerase chain reaction for the detection of ocular chlamydial infection in trachoma-endemic communities. , 1994, The Journal of infectious diseases.

[51]  H. Whittle,et al.  A longitudinal study of trachoma in a Gambian village: implications concerning the pathogenesis of chlamydial infection , 1992, Epidemiology and Infection.

[52]  Mike Hurwicz,et al.  Risks and opportunities , 1991 .

[53]  A. Foster,et al.  National survey of blindness and low vision in The Gambia: results. , 1989, The British journal of ophthalmology.

[54]  H. Whittle,et al.  GENITAL AND NEONATAL CHLAMYDIAL INFECTION IN A TRACHOMA ENDEMIC AREA , 1982, The Lancet.

[55]  D. Hobson,et al.  Maternal genital chlamydial infection as a cause of neonatal conjunctivitis. , 1977, Postgraduate medical journal.

[56]  S. Wang,et al.  Human serology in Chlamydia trachomatis infection with microimmunofluorescence. , 1974, The Journal of infectious diseases.

[57]  WU KarenT,et al.  Results , 1969 .

[58]  E. S. Pearson,et al.  THE USE OF CONFIDENCE OR FIDUCIAL LIMITS ILLUSTRATED IN THE CASE OF THE BINOMIAL , 1934 .

[59]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[60]  M. Fay,et al.  Wilcoxon-Mann-Whitney or t-test? On assumptions for hypothesis tests and multiple interpretations of decision rules. , 2010, Statistics surveys.

[61]  Peter Dalgaard,et al.  R Development Core Team (2010): R: A language and environment for statistical computing , 2010 .

[62]  Mary M. Alleman,et al.  Weekly epidemiological record Relevé épidémiologique hebdomadaire , 2003 .